Table 2. Estimates of Life Expectancy for Men and Women With Type 1 Diabetes Under Conditions of Preserved Renal Function Compared With the General Population Without Type 1 Diabetes in Scotland 2008-2010.
| Age Interval, y | Modified Death Rate per 1000 Person-Years in Type 1 Diabetes Populationb | Estimated Additional Life Expectancy, (95% CI), ya | ||
|---|---|---|---|---|
| Type 1 Diabetes With Preserved Renal Function | General Population Without Type 1 Diabetes | Difference in Life Expectancy, y | ||
| Men | ||||
| 20-24 | 2.3 | 49.0 (47.2 to 50.7) | 57.3 (57.2 to 57.4) | 8.3 (6.5 to 10.1) |
| 25-29 | 2.5 | 44.5 (42.8 to 46.2) | 52.5 (52.4 to 52.6) | 8.0 (6.3 to 9.7) |
| 30-34 | 2.9 | 40.0 (38.4 to 41.6) | 47.8 (47.7 to 47.9) | 7.8 (6.2 to 9.4) |
| 35-39 | 6.4 | 35.6 (34.0 to 37.2) | 43.1 (43.0 to 43.2) | 7.5 (5.9 to 9.1) |
| 40-44 | 7.3 | 31.6 (30.2 to 33.2) | 38.4 (38.3 to 38.5) | 6.8 (5.3 to 8.3) |
| 45-49 | 10.3 | 27.7 (26.3 to 29.2) | 33.8 (33.7 to 33.9) | 6.1 (4.6 to 7.6) |
| 50-54 | 12.5 | 24.1 (22.7 to 25.5) | 29.3 (29.2 to 29.4) | 5.2 (3.8 to 6.6) |
| 55-59 | 17.4 | 20.5 (19.2 to 21.9) | 25.0 (24.9 to 25.0) | 4.5 (3.1 to 5.9) |
| 60-64 | 26.4 | 17.1 (15.9 to 18.5) | 20.8 (20.7 to 20.9) | 3.7 (2.4 to 5.0) |
| 65-69 | 37.5 | 14.2 (13.0 to 15.5) | 17.0 (16.9 to 17.0) | 2.8 (1.6 to 4.1) |
| 70-74 | 67.1 | 11.6 (10.5 to 12.8) | 13.5 (13.4 to 13.6) | 1.9 (0.7 to 3.1) |
| 75-79 | 68.2 | 10.3 (9.2 to 11.4) | 10.4 (10.4 to 10.5) | 0.1 (−1.0 to 1.2) |
| ≥80 | 118.1 | 8.5 (7.8 to 9.2) | 7.8 (7.7 to 7.8) | −0.7 (−1.4 to 0.0) |
| Women | ||||
| 20-24 | 2.0 | 53.1 (50.7 to 55.5) | 61.0 (60.9 to 61.1) | 7.9 (5.5 to 10.3) |
| 25-29 | 1.5 | 48.6 (46.3 to 50.9) | 56.1 (56.0 to 56.2) | 7.5 (5.2 to 9.8) |
| 30-34 | 3.0 | 44.0 (41.7 to 46.2) | 51.2 (51.1 to 51.3) | 7.2 (4.9 to 9.5) |
| 35-39 | 3.6 | 39.6 (37.4 to 41.8) | 46.3 (46.3 to 46.4) | 6.7 (4.5 to 8.9) |
| 40-44 | 4.6 | 35.3 (33.1 to 37.4) | 41.6 (41.5 to 41.6) | 6.3 (4.1 to 8.5) |
| 45-49 | 7.8 | 31.0 (29.0 to 33.1) | 36.8 (36.8 to 36.9) | 5.8 (3.7 to 7.9) |
| 50-54 | 10.0 | 27.2 (25.2 to 29.1) | 32.2 (32.1 to 32.3) | 5.0 (3.0 to 7.0) |
| 55-59 | 11.7 | 23.4 (21.5 to 25.3) | 27.7 (27.6 to 27.8) | 4.3 (2.4 to 6.2) |
| 60-64 | 16.8 | 19.7 (17.9 to 21.5) | 23.4 (23.3 to 23.5) | 3.7 (1.9 to 5.5) |
| 65-69 | 22.3 | 16.2 (14.5 to 17.9) | 19.3 (19.2 to 19.3) | 3.1 (1.4 to 4.8) |
| 70-74 | 44.4 | 12.8 (11.3 to 14.3) | 15.5 (15.4 to 15.5) | 2.7 (1.2 to 4.2) |
| 75-79 | 67.0 | 10.3 (9.0 to 11.7) | 12.0 (11.9 to 12.0) | 1.7 (0.3 to 3.1) |
| ≥80 | 118.7 | 8.4 (7.7 to 9.1) | 9.0 (8.9 to 9.0) | 0.6 (−0.1 to 1.3) |
a
Estimated additional life expectancy in years at each attained age interval conditional on survival until the start of that age interval.
b
Modified death rates obtained by reducing the observed rates by the fraction of deaths attributable to having an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2, attributable to having an estimated glomerular filtration rate less than 90 mL/min/1.73 m2, based on 21 011 participants with eGFR data.